Catridecacog

Basic Information

Item Value
DrugBank ID DB09310
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 46

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 primary release disorder of platelets KG + DL
2 pseudo-von Willebrand disease KG + DL
3 Glanzmann thrombasthenia KG + DL
4 congenital factor XIII deficiency KG + DL
5 hemophilia KG + DL
6 Scott syndrome KG + DL
7 acquired coagulation factor deficiency KG + DL
8 bleeding diathesis due to a collagen receptor defect KG + DL
9 hemorrhagic disorder due to a constitutional thrombocytopenia KG + DL
10 acquired hemophilia KG + DL
11 fetal and neonatal alloimmune thrombocytopenia KG + DL
12 thrombotic thrombocytopenic purpura KG + DL
13 thrombophilia, X-linked, due to factor 9 defect KG + DL
14 thrombocytopenic purpura KG + DL
15 inherited thrombophilia KG + DL
16 platelet-type bleeding disorder KG + DL
17 autosomal dominant macrothrombocytopenia KG + DL
18 flood factor deficiency KG + DL
19 hemophilia A with vascular abnormality KG + DL
20 hereditary thrombocytosis with transverse limb defect KG + DL
21 familial thrombomodulin anomalies KG + DL
22 heparin cofactor 2 deficiency KG + DL
23 factor XI deficiency KG + DL
24 Ehlers-Danlos syndrome, fibronectinemic type KG + DL
25 methylcobalamin deficiency type cblG KG + DL
26 malignant peritoneal mesothelioma KG + DL
27 congenital factor V deficiency KG + DL
28 monosomy X KG + DL
29 thrombomodulin-related bleeding disorder KG + DL
30 pleural mesothelioma KG + DL
31 inherited prekallikrein deficiency KG + DL
32 congenital factor XI deficiency KG + DL
33 congenital fibrinogen deficiency KG + DL
34 pleural adenomatoid tumor KG + DL
35 pleural biphasic mesothelioma KG + DL
36 symptomatic form of hemophilia in female carriers KG + DL
37 lymphohistiocytoid mesothelioma KG + DL
38 well differentiated papillary mesothelioma KG + DL
39 factor 5 excess with spontaneous thrombosis KG + DL
40 hemorrhagic disorder due to a platelet anomaly KG + DL
41 acquired von willebrand syndrome KG + DL
42 pleural epithelioid mesothelioma KG + DL
43 pleural sarcomatoid mesothelioma KG + DL
44 pericardium cancer KG + DL
45 iminoglycinuria KG + DL
46 pseudoachondroplasia KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.